Pancreatic Cancer Research

ResearcherHunan Normal UniversityActive in the last 2 years

Hong‐Wen Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8757-1620; OpenAlex author ID A5023219110. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 2 papers

Papers 7

  1. Dual‑Channel Hypoxia Detection Using PET-Based Water-Soluble Cyanine Probes to Suppress False Negatives in Image‑Guided Pancreatic Cancer Resection. Last author DOI 10.1002/adhm.71693↗
  2. Charge transfer modulation in anionic Cy5-Protein afterglow nanoprobe enables precise pancreatic cancer surgery and efficient metastasis inhibition. Last author DOI 10.1016/j.biomaterials.2026.124392↗
  3. A Self-Calibrating Fluorescent-Photoacoustic Integrated Probe Enables Fast Visualizing Pancreatic Cancer and Imaging-Guided Tumor Surgery. First author DOI 10.1002/smll.202408527↗
  4. Active-Targeted ICG for Surgical Navigation and Fluorescence-Guided Laparoscopic Photothermal Ablation in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1021/acs.analchem.4c04575↗
  5. JS-K Combined with a Melanin-Based Theranostic Agent: A Novel Sequential Delivery Strategy to Enhance the Near-Infrared Fluorescence Imaging of Pancreatic Duct… Co-author DOI 10.1021/acs.analchem.3c04914↗
  6. NIR Fluorescent/Photoacoustic Bimodal Imaging of Ferroptosis in Pancreatic Cancer Using Biothiols-Activable Probes. Last author DOI 10.1021/acs.analchem.4c00922↗
  7. Endoscopically guided interventional photodynamic therapy for orthotopic pancreatic ductal adenocarcinoma based on NIR-II fluorescent nanoparticles. Co-author DOI 10.7150/thno.84164↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei Cheng · 4 shared papers, 2023–2025 · strength 0.88
  2. Haifeng Ge · 3 shared papers, 2024–2026 · strength 0.86
  3. Lei Zhou · 3 shared papers, 2024–2025 · strength 0.73
  4. Manxiong Dai · 2 shared papers, 2024–2025 · strength 0.45
  5. Kang Chen · 2 shared papers, 2024–2025 · strength 0.45
  6. Ning Zhou · 2 shared papers, 2023–2024 · strength 0.36
  7. Huiling Huang · 1 shared paper, 2026 · strength 0.30
  8. Cong Hu · 1 shared paper, 2025 · strength 0.28
  9. Lingyun Li · 1 shared paper, 2024 · strength 0.23
  10. Xu Chen · 1 shared paper, 2023 · strength 0.15
  11. Sulai Liu · 1 shared paper, 2023 · strength 0.15
  12. Yan Liao · 1 shared paper, 2023 · strength 0.15
  13. Kang Chen · 1 shared paper, 2023 · strength 0.15
  14. Guosheng Song · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.